heptanoic acids

Preferred Label : heptanoic acids;

MeSH definition : 7-carbon saturated monocarboxylic acids.;

MeSH synonym : acids, heptanoic;

Wikipedia link : https://en.wikipedia.org/wiki/Heptanoic acids;

Is substance : O;

Details

Origin ID

D006538;

UMLS CUI

C0019227;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Heptanoic Acid [NCIt concept]
- Heptanoic acid (substance) [SNOMED CT concept]
- heptanoic acid [SNOMED Notion]
Record concept(s)
- heptanoic acids [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2S,6R)-diamino-(5R,7)-dihydroxy-heptanoic acid [MeSH Supplementary Concept]
- (Z)-7-((1R,2R,3S,5S)-2-(benzothiophen-3-ylcarbonylamide)-10-norpinan-3-yl)hept-5-enoic acid [MeSH Supplementary Concept]
- 2,2,6,6-tetramethylpiperidin-4-yl heptanoate [MeSH Supplementary Concept]
- 2,6,7-trideoxy-7-C-(2,4-dichlorophenyl)heptonic acid [MeSH Supplementary Concept]
- 2-(1,3-dihydroxy-but-2-enylidene)-6-methyl-3-oxo-heptanoic acid [MeSH Supplementary Concept]
- 2-(4-methylphenoxy)-7-(4-chlorophenyl)heptanoic acid [MeSH Supplementary Concept]
- 2-(4-tert-butylphenoxy)-7-(4-chlorophenyl)heptanoic acid [MeSH Supplementary Concept]
- 2-hydroxyatorvastatin [MeSH Supplementary Concept]
- 3,7-diamino-2-hydroxyheptanoyl-alanyl-proline [MeSH Supplementary Concept]
- 3,7-diamino-2-hydroxyheptanoyl-leucyl-proline [MeSH Supplementary Concept]
- 3-(2',2'-dibromo-1-methylcyclopropyl)-6-oxoheptanoic acid [MeSH Supplementary Concept]
- 3-(2',2'-dichloro-1'-methylcyclopropyl)-6-oxoheptanoic acid [MeSH Supplementary Concept]
- 3-hydroxyisoheptanoic acid [MeSH Supplementary Concept]
- 4,7-diamino-2,3-dihydroxyheptanoic acid [MeSH Supplementary Concept]
- 4,8,12,16-tetramethylheptanoic acid [MeSH Supplementary Concept]
- 4-amido-7-guanidino-2,3-dihydroxyheptanoic acid [MeSH Supplementary Concept]
- 4-hydroxyatorvastatin [MeSH Supplementary Concept]
- 4-methyl-4-(octadecyloxycarbonylamino)heptanedioic acid [MeSH Supplementary Concept]
- 4-oxo-6-hydroxyheptanoic acid [MeSH Supplementary Concept]
- 5(S),6(R)-7-trihydroxyheptanoic acid, methyl ester [MeSH Supplementary Concept]
- 6-methyl-4-((2-oxopentadecanoyl)amino)heptanoic acid [MeSH Supplementary Concept]
- 7,7,7-triphenylheptanoic acid [MeSH Supplementary Concept]
- 7-(2-(4-fluorophenyl)-4-isopropyl-5-(4-methylbenzylcarbamoyl)-2H-pyrazol-3-yl)-3,5-dihydroxyheptanoic acid [MeSH Supplementary Concept]
- 7-(4-((3-fluorobenzyl)carbamoyl)-5-cyclopropyl-2-(4-fluorophenyl)-1H-imidazol-1-yl)-3,5-dihydroxyheptanoic acid [MeSH Supplementary Concept]
- 7-(4-(4-(((4-cyclohexylbutyl)amino)carbonyl)-2-oxazolyl)phenyl)-7-(3-pyridyl)hept-6-enoic acid [MeSH Supplementary Concept]
- 7-mercaptoheptanoic acid [MeSH Supplementary Concept]
- GP 45699 [MeSH Supplementary Concept]
- KMN-159 [MeSH Supplementary Concept]
- L-2-amino-7-carboxamidoheptanoic acid [MeSH Supplementary Concept]
- NCX 6560 [MeSH Supplementary Concept]
- S 17733 [MeSH Supplementary Concept]
- U 64846 [MeSH Supplementary Concept]
- amlodipine, atorvastatin drug combination [MeSH Supplementary Concept]
- cyclopentane-2-oxo-1-heptanoic acid [MeSH Supplementary Concept]
- embellistatin [MeSH Supplementary Concept]
- ganoderic acid A [MeSH Supplementary Concept]
- ganoderic acid F [MeSH Supplementary Concept]
- ganoderic acid H [MeSH Supplementary Concept]
- isodomoic acid A [MeSH Supplementary Concept]
- isodomoic acid B [MeSH Supplementary Concept]
- isodomoic acid C [MeSH Supplementary Concept]
- isodomoic acid E [MeSH Supplementary Concept]
- isodomoic acid F [MeSH Supplementary Concept]
- isodomoic acid G [MeSH Supplementary Concept]
- isodomoic acid H [MeSH Supplementary Concept]
- ketomethylenebestatin [MeSH Supplementary Concept]
- liptruzet [MeSH Supplementary Concept]
- perfluoro-n-heptanoic acid [MeSH Supplementary Concept]
- poly(4-acryloylamine-4-(carboxyethyl)heptanodioic acid [MeSH Supplementary Concept]
- pteridic acid A [MeSH Supplementary Concept]
- pteridic acid B [MeSH Supplementary Concept]
- pteridic acid C [MeSH Supplementary Concept]
- pteridic acid hydrate [MeSH Supplementary Concept]
- sch 31828 [MeSH Supplementary Concept]
- seratrodast [MeSH Supplementary Concept]
- vapiprost [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
Validated automatic mappings to BTNT
- heptanoic acid [Substance BNPC]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients